Scholarlink

<p>Dengue virus (DENV) remains a major global health threat, and no clinically approved antiviral therapy is currently available. Halogenated biscoumarins have been reported as versatile antimicrobial and antiviral agents. Here, we screened eleven halogenated biscoumarin derivatives against DENV and identified compounds 3 and 4—bearing chlorine substitutions at the 3- or 4-position of the phenyl moiety—as the most potent inhibitors of DENV2, with EC<sub>50</sub> values of 3.62–9.72 µM and 4.62–10.88 µM, respectively, and selectivity indices (SI) up to 20.97. Both compounds also inhibited all four DENV serotypes and Zika virus (ZIKV) with comparable efficacy. Mechanistic analyses demonstrated that compounds 3 and 4 significantly suppressed viral translation and RNA replication in infectious and replicon models. Long-term passaging generated mutations in NS4B, although these substitutions did not confer resistance, was involved in self-dimerization to curvature formation of ER-derived spherules, which may reflect adaptive changes linked to host interaction. In vitro enzymatic assays further indicated that the viral NS5 methyltransferase is a potential target, with IC<sub>50</sub> values of 4.60 ± 0.83 µM and 3.17 ± 0.25 µM for compounds 3 and 4, respectively, and both compounds inhibited NS3 protease activity by &gt; 89% at 50 µM. Collectively, these results identify chlorinated biscoumarins as promising antiviral scaffolds that impair flaviviral translation and replication, supporting their further optimization and in vivo evaluation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Chlorinated bis-4-hydroxycoumarins suppress flavivirus replication by inhibiting dengue virus type 2 translation and replication

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月16日

查看全文
  • Naphat Loeanurit,
  • Thi-Hong-Truc Phan,
  • Kowit Hengphasatporn,
  • Thanchanok Chanachanvong,
  • Borwornlak Toopradab,
  • Phornphimon Maitarad,
  • Prangwalai Chanchaem,
  • Vorthon Sawaswong,
  • Sunchai Payungporn,
  • Ajirawadee Suwanchan,
  • Auwal Rabiu Auwal,
  • Kittikhun Wangkanont,
  • Thanyada Rungrotmongkol,
  • Yasuteru Shigeta,
  • Tanatorn Khotavivattana,
  • Warinthorn Chavasiri,
  • Siwaporn Boonyasuppayakorn

摘要

Dengue virus (DENV) remains a major global health threat, and no clinically approved antiviral therapy is currently available. Halogenated biscoumarins have been reported as versatile antimicrobial and antiviral agents. Here, we screened eleven halogenated biscoumarin derivatives against DENV and identified compounds 3 and 4—bearing chlorine substitutions at the 3- or 4-position of the phenyl moiety—as the most potent inhibitors of DENV2, with EC50 values of 3.62–9.72 µM and 4.62–10.88 µM, respectively, and selectivity indices (SI) up to 20.97. Both compounds also inhibited all four DENV serotypes and Zika virus (ZIKV) with comparable efficacy. Mechanistic analyses demonstrated that compounds 3 and 4 significantly suppressed viral translation and RNA replication in infectious and replicon models. Long-term passaging generated mutations in NS4B, although these substitutions did not confer resistance, was involved in self-dimerization to curvature formation of ER-derived spherules, which may reflect adaptive changes linked to host interaction. In vitro enzymatic assays further indicated that the viral NS5 methyltransferase is a potential target, with IC50 values of 4.60 ± 0.83 µM and 3.17 ± 0.25 µM for compounds 3 and 4, respectively, and both compounds inhibited NS3 protease activity by > 89% at 50 µM. Collectively, these results identify chlorinated biscoumarins as promising antiviral scaffolds that impair flaviviral translation and replication, supporting their further optimization and in vivo evaluation.